P276-00
Sponsors
Piramal Enterprises Limited
Conditions
Mantle Cell LymphomaMelanomaMultiple MyelomaNeoplasmPancreatic CancerRadiation Induced Mucositis in Head and Neck CancerRelapsed and/or Refractory Multiple MyelomaSquamous Cell Carcinoma of Head and Neck
Phase 1
Phase I Study of P276-00 in Patients With Advanced Refractory Neoplasms
TerminatedNCT00408018
Start: 2006-03-31End: 2008-10-31Updated: 2009-01-01
Open Label Phase I Study of P276-00 in Patients With Advanced Refractory Neoplasms
CompletedNCT00407498
Start: 2005-05-31End: 2008-09-30Updated: 2009-01-01
Phase I Study for Safety and Efficacy of P276-00 in Subjects With Myeloma
WithdrawnNCT00547404
Start: 2008-12-31End: 2010-07-31Target: 35Updated: 2009-04-23
Study To Evaluate Safety and Efficacy of P276-00 in Subjects With Refractory Multiple Myeloma
CompletedNCT00882063
Start: 2008-01-31End: 2012-05-31Updated: 2012-11-21
Safety and Efficacy Study of P276-00 in Combination With Radiation in Subjects With Advanced Head and Neck Cancer
CompletedNCT00899054
Start: 2009-08-31End: 2012-11-30Updated: 2012-11-22
Safety and Efficacy Study of P276-00 in Combination With Gemcitabine in Patients With Advanced Pancreatic Cancer
CompletedNCT00898287
Start: 2009-05-31Updated: 2012-01-20
Phase 2
A Phase II Clinical Trial to Study the Efficacy and Safety of a New Drug P276-00 in Treatment of Recurrent and/or Locally Advanced Head and Neck Cancer
CompletedNCT00824343
Start: 2008-09-30End: 2013-06-30Updated: 2013-07-10
Efficacy Study Of P276-00 In Subjects Of Malignant Melanoma Positive For Cyclin D1 Expression
CompletedNCT00835419
Start: 2009-05-31End: 2012-11-30Updated: 2012-12-04
A Phase II Study to Evaluate Efficacy and Safety of P276-00 in Relapsed and/or Refractory Mantle Cell Lymphoma
TerminatedNCT00843050
Start: 2009-11-30End: 2012-08-31Updated: 2012-07-27
A Study to Assess Radiation Induced Mucositis in Patients of Head and Neck Cancer Administered Chemo-Radiation With or Without P276-00
CompletedNCT01903018
Start: 2012-07-31End: 2014-09-30Updated: 2014-09-04